Photoreceptor protection by mesenchymal stem cell transplantation identifies exosomal MiR-21 as a therapeutic for retinal degeneration

• Published in: Cell death and differentiation 2021-03, Vol.28 (3), p.1041-1061
• Main Authors: Deng, Chun-Lei, Hu, Cheng-Biao, Ling, Sheng-Tao, Zhao, Na, Bao, Li-Hui, Zhou, Feng, Xiong, Ye-Cheng, Chen, Tao, Sui, Bing-Dong, Yu, Xiao-Rui, Hu, Cheng-Hu
• Format: Article
• Language: English
• Subjects: 13/1; 13/100; 13/109; 13/2; 13/31; 13/89; 14/19; 14/28; 14/34; 14/63; 38/71; 38/77; 38/90; 631/337/176; 64/110; 64/60; 692/308/2171; 692/308/575; 692/699; Animals; Apoptosis; Biochemistry; Biomedical and Life Sciences; Cell Biology; Cell Cycle Analysis; Cell death; Disease Models, Animal; Exosomes; Extracellular vesicles; Eye disorders; Female; Life Sciences; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal stem cells; Methylnitrosourea - toxicity; Mice; Mice, Inbred C57BL; MicroRNAs - genetics; MicroRNAs - metabolism; N-Methyl-N-nitrosourea; Nonsense mutation; Phosphodiesterase; Photoreceptor Cells, Vertebrate - metabolism; Photoreceptors; Retina; Retina - metabolism; Retinal degeneration; Retinal Degeneration - chemically induced; Retinal Degeneration - metabolism; Retinal Degeneration - prevention & control; Stem cell transplantation; Stem Cells; Visual perception
• ISSN: 1350-9047; 1476-5403
• DOI: 10.1038/s41418-020-00636-4

Photoreceptor apoptosis is recognized as one key pathogenesis of retinal degeneration, the counteraction of which represents a promising approach to safeguard visual function. Recently, mesenchymal stem cell transplantation (MSCT) has demonstrated immense potential to treat ocular disorders, in which extracellular vesicles (EVs), particularly exosomes, have emerged as effective ophthalmological therapeutics. However, whether and how MSCT protects photoreceptors against apoptotic injuries remains largely unknown. Here, we discovered that intravitreal MSCT counteracted photoreceptor apoptosis and alleviated retinal morphological and functional degeneration in a mouse model of photoreceptor loss induced by N -methyl- N -nitrosourea (MNU). Interestingly, effects of MSCT were inhibited after blockade of exosomal generation by GW4869 preconditioning. Furthermore, MSC-derived exosomal transplantation (EXOT) effectively suppressed MNU-provoked photoreceptor injury. Notably, therapeutic efficacy of MSCT and EXOT on MNU-induced retinal degeneration was long-lasting as photoreceptor preservance and retinal maintenance were detected even after 1–2 months post to injection for only once. More importantly, using a natural occurring retinal degeneration model caused by a nonsense mutation of Phosphodiesterase 6b gene ( Pde6b mut ), we confirmed that MSCT and EXOT prevented photoreceptor loss and protected long-term retinal function. In deciphering therapeutic mechanisms regarding potential exosome-mediated communications, we identified that miR-21 critically maintained photoreceptor viability against MNU injury by targeting programmed cell death 4 (Pdcd4) and was transferred from MSC-derived exosomes in vivo for functional regulation. Moreover, miR-21 deficiency aggravated MNU-driven retinal injury and was restrained by EXOT. Further experiments revealed that miR-21 mediated therapeutic effects of EXOT on MNU-induced photoreceptor apoptosis and retinal dysfunction. These findings uncovered the efficacy and mechanism of MSCT-based photoreceptor protection, indicating exosomal miR-21 as a therapeutic for retinal degeneration.